Substantial world-wide resources are being committed to develop improved toxicological testing methods that will contribute to better protection of human health and the environment. The development of new methods is intrinsically driven by new knowledge emanating from fundamental research in toxicology, carcinogenesis, molecular biology, biochemistry, computer sciences, and a host of other disciplines. Critical evaluations and strong scientific consensus are essential to facilitate adoption of alternative methods for use in the safety assessment of drugs, chemicals, and other environmental factors. Recommendations to hasten the development of new alternative methods included increasing emphasis on the development of mechanism-based methods, increasing fundamental toxicological research, increasing training on the use of alternative methods, integrating accepted alternative methods into toxicity assessment, internationally harmonizating chemical toxicity classification schemes, and increasing international cooperation to develop, validate, and gain acceptance of alternative methods. Environ Health Perspect 1 06(Suppl 2): 413-418 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/413-4 18blaauboer/abstracthtml
Introduction
Countries commit considerable resources to used as drugs, pesticides, food additives, determine the potential of chemicals to cause cosmetics, and industrial processes, or adverse effects to humans or their envi-those found in consumer products. Specific ronment. Such efforts apply to chemicals approaches incorporate a series of tests, commonly involving laboratory animals, to first ascertain the potential of a chemical to cause an array of toxic effects, e.g., ocular toxicity, infertility, nervous disorders, cancer, etc. The array of toxic end points, and relevant protocols to detect such effects, are usually determined by regulatory agencies, based on the recommendation of their own scientists or ad hoc groups of scientific experts. Thus, the nature of testing evolves with advances in scientific knowledge; new end points may be identified or refinements proposed for methods used to assess previously selected end points. The overall goal is to devise strategies that prevent adverse impacts on the health of the public and the environment.
Alternative Test Methods for the Protection of Human Health and the Environment
Risk assessment refers to a structured sequence of analyses by which one reviews and characterizes the potential toxic properties of a chemical. Such analyses usually incorporate separate but integrated judgments based on qualitative and quantitative criteria. The qualitative process identifies the type and quantity of information needed and then reviews and integrates that information to reach a judgement as to the potential of a chemical to cause adverse effects. In rendering a qualitative judgment, one determines that there are adequate data to conclude that an adverse effect has been observed or could be anticipated and, if not in the species of concern, that the effect may occur in the subjects of concern, i.e., humans, ecosystems, etc. The subsequent step employs procedures that express the potential of the chemical to cause such effects at specified levels of exposure, with particular focus on the lowest doses that cause such effects and the changes in incidence or severity of the effects with increasing dose.
Many of the toxicology tests in common use today were designed and modified according to clinical and physiological criteria selected on the basis of the commonality of the observation, e.g., organ dysfunction, cancer, infertility, or birth defects, rather than understanding the underlying pathobiology of the process. Thus, tests were empirical and acceptance was based on correlation with observations in humans.
Alternatives to these empirical tests have been developed to A mechanism has been defined as an explanation of an observed phenomenon that explains the processes underlying the phenomenon in terms of events at lower levels of organization (3). Thus, a mechanistic test is based on a system at an acceptable level of organization and a relevant end point based on a sufficient understanding of the cellular and/or molecular basis of the effect under consideration. An example is a test based on interaction with a defined receptor, which is a critical or pivotal stage in the development of an effect.
Fidelity, Discrimination, Analogy, Mechanism, and Correlation. Fidelity is the accuracy with which a model reproduces the overall properties of what is being modeled, whereas discrimination is the accuracy with which a model reproduces a particular property or properties of what is being modeled. No model can offer 100% fidelity or 100% discrimination, but the best models will have the highest possible fidelity in combination with the highest possible discrimination. In general, a low fidelity/high discrimination model is more Environmental Health Perspectives * Vol 106, Supplement 2 * April 1998 likely to be useful than a high fidelity/low discrimination model (4) .
The assumed relevance of animal tests to humans is based on the general high fidelity of animal models, i.e., on analogy (where similarity in a particular circumstance is inferred from agreement or similarity in an acceptable number of other features in the systems being compared), and not on mechanism (where similarity is based on an adequate knowledge of the mechanistic basis of the phenomenon under consideration and its operation in the systems being compared). In any case, similarity does not mean identity, so judgment in the interpretation of the meaning of data will always be necessary, whatever the model may be.
Correlative approaches, based solely on statistical relationships between phenomena that cannot be explained on a mechanistic basis, are unlikely to lead to correlative nonanimal tests that will receive widespread acceptance. This will apply even where such tests would be more useful than existing animal tests that also lacked a sufficient mechanistic basis.
Some qualitative and quantitative structure-activity relationship (SAR) models generally represent correlative approaches; but mechanistic SAR approaches are also being developed, e.g., when interactions with specific receptors can be predicted from structure and the consequences of such interactions are understood (see also the section on QSAR).
High The trend toward alternative methods will undoubtedly lead to a wider variety of approaches to hazard prediction and risk assessment. This will be due to the much greater range of technologies and methods that will have to be applied. Often, data provided by various methods will have to be combined and integrated as contributions to the overall decisionmaking process. This, in turn, will lead to the need for a wider range of equipment, expertise, and experience. These new approaches will be effective only if they result in integrated, stepwise, and tier-testing strategies, aimed at giving the most relevant, reliable, and useful outcomes quickly and inexpensively (10) .
These new methods, new skills, and new strategies will require training programs to provide personnel, and data banks to provide ready access to test protocols, prediction models, outcomes of validation studies, and evidence of experience in use. Ideally, this approach would be based on international cooperation, leading to the greater harmonization of test guidelines and to agreement on the principles of validation and acceptance of alternative methods.
The development of unnecessary tests must be avoided. The need for a new test in relation to other tests that could provide the same sort of information should be satisfactorily established at an early stage of test development.
Integration into a Strategy
In a toxicological risk assessment it is logical to take into consideration information from all available sources. How this is done is highly dependent on the goal of the risk assessment process. In many cases it is subject to the judgment of the person conducting the exercise. Such information can include animal data, epidemiological data, mechanistically based information derived from in vitro models, or computergenerated data. Examples from several of these approaches are cited in accompanying documents (4, 5, 8, 9 
